Why did AFX.DE stock drop pre-market today?

AFX.DE stock fell after preliminary Q1 revenue of **€467.00m** missed last year and EBITA dropped to **€8.00m**. Management said fiscal guidance will likely be missed and will be reviewed, driving the pre-market sell-off.

What is the next catalyst for AFX.DE stock?

The next key catalyst is the quarterly statement on **2026-02-12**. Management will update guidance and re-organization measures by the six-month call on **2026-05-12**.

What price targets and forecast exist for AFX.DE stock?

Meyka AI projects a monthly level of **€50.54**, implying **72.29%** upside versus **€29.34**. We list targets: conservative **€28.00**, base **€40.00**, bullish **€52.00**. Forecasts are model-based and not guarantees.

Is AFX.DE stock a buy after the drop?

Meyka AI currently rates AFX.DE Grade **B** with a HOLD suggestion. The stock has reasonable valuation metrics but faces guidance risk. Wait for the official Q1 report and clearer guidance before buying.

DE Stocks

Down 16.65% pre-market: AFX.DE Carl Zeiss Meditec AG (XETRA) guidance in focus

ByDanny Kontos January 23, 2026January 23, 2026

AFX.DE stock plunged 16.65% pre-market to €29.34 after Carl Zeiss Meditec AG reported weak preliminary Q1 results and said full-year guidance is likely under review. The sharp move comes on 3,011,798.00 shares, well above the 180,570.00 average. We see this as a liquidity-driven sell-off tied to guidance risk and currency headwinds.